Loading clinical trials...

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01848730

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

To investigate the effect of repeat oral dosing of CNV2197944 75 mg tid on the pain experienced in post-herpetic neuralgia (PHN) as measured by changes in PI-NRS after three weeks of treatment compare...

Lead sponsor: Convergence Pharmaceuticals•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 4

Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

NCT00159666 · Post-Herpetic Neuralgia

COMPLETEDPhase 2

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety

NCT02065349 · Post-Herpetic Neuralgia (PHN), Neuropathic Pain, and more

UNKNOWNNA

Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia

NCT03120962 · Herpes Zoster, Post-herpetic Neuralgia

COMPLETEDNA

Reduction of Postherpetic Neuralgia in Herpes Zoster

NCT01250561 · Herpes Zoster, Post-herpetic Neuralgia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 30, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment103

Start dateApr 2013

Last updatedOct 30, 2014

Condition

Post-herpetic Neuralgia

Locations shown

Christiaan Barnard Memorial Hospital

Cape Town

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions